Artificial Internal Organs Market Research, 2033
The global artificial internal organs market was valued at $27.4 billion in 2023, and is projected to reach $56.8 billion by 2033, growing at a CAGR of 7.5% from 2024 to 2033. Increase in the prevalence of chronic diseases and surge in the demand for organ transplants is the driving factor of the market.
Market Introduction and Definition
Artificial internal organs refer to engineered substitutes for natural organs within the human body. These substitutes are designed to perform the same functions as their natural counterparts, thereby restoring or maintaining bodily functions in individuals whose organs may be damaged, dysfunctional, or otherwise impaired. The development of artificial internal organs is a significant advancement in medical technology and has the potential to revolutionize healthcare by addressing organ shortages for transplantation, providing temporary support during recovery, or offering permanent solutions for chronic conditions.
Key Takeaways
- The artificial internal organs market share study covers 20 countries. The research includes a segment analysis of each country in terms of value (Billion) for the projected period 2024-2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major artificial internal organs industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.
Key Market Dynamics
The artificial internal organs market growth is influenced by the increasing demand for organ transplants. There is a persistent shortage of donor organs worldwide, leading to long waiting lists and high mortality rates among patients awaiting transplants. Artificial internal organs provide an alternative solution to bridge this gap and reduce dependency on scarce donor organs. In addition, rapid advancements in materials science, biotechnology, and robotics have significantly enhanced the capabilities and functionalities of artificial internal organs.
Improved biocompatibility, durability, and functionality are making these devices more viable and effective in clinical settings. Furthermore, chronic diseases such as cardiovascular diseases, diabetes, kidney failure, and respiratory disorders are on the rise globally, and thus is an artificial internal organs market opportunity. Artificial internal organs offer therapeutic options for managing these conditions, improving patient outcomes, and enhancing quality of life. Moreover, the aging population is more susceptible to organ failure and chronic diseases, driving the demand for innovative medical solutions such as artificial internal organs to address age-related health issues.
Also, rising healthcare expenditures globally are fueling investments in advanced medical technologies, including artificial internal organs. Healthcare providers are increasingly willing to adopt these technologies to improve patient care and operational efficiencies. Thus, the aforementioned factors are anticipated to drive the artificial internal organs market forecast.
Patent Analysis of Global Artificial Internal Organs Market, 2015-2024*
Although the growth of the artificial internal organs market has been more rapid in recent years, the industry can draw on the patents filed by various companies. For instance, patents filed by the companies based in Japan dominated the same with 26.3% share, Patent Cooperation Treaty (PCT) , holds a share of about 11.9%, China holds a share of about 18.6% and other countries held a share of about 29.7%.
Market Segmentation
The artificial internal organs market size is segmented into type, end user, and region. By type, the market is categorized into artificial heart, artificial kidney, artificial lungs, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America accounted for a major artificial internal organs market size owing to advanced healthcare infrastructure, robust research and development capabilities, strong regulatory frameworks, and significant investment. These factors, combined with a strong presence of major key players, contribute to the region’s leading position in the market. Moreover, the rise in the number of clinical trials and high healthcare expenditure from the government organizations in the region drive the growth of the market.
Asia-Pacific artificial internal organs market share is estimated to grow with the highest CAGR during the forecast period owing to increase in healthcare investments and government initiatives toward advancement of medical technologies. Moreover, rise in number of road accidents and injuries as well as increase in purchasing power of the p in populated countries, such as China and India. The countries in Asia-Pacific possess a huge population base and increasing geriatric population boosting the market.
Industry Trends
A trend toward smaller, more compact artificial organs has been witnessed that integrate advanced technologies such as sensors, microelectronics, and wireless connectivity. This trend aims to enhance functionality, improve patient comfort, and enable remote monitoring and management.
Advances in genomics and biotechnology are driving a shift towards personalized medicine. Artificial internal organs are increasingly tailored to individual patient needs, considering genetic profiles, physiological parameters, and disease characteristics to optimize treatment outcomes.
Competitive Landscape
The major players operating in the artificial internal organs industry include SynCardia Systems LLC, Abbott Laboratories, Cochlear Limited, Boston Scientific Corporation, Johnson & Johnson, Edwards Lifesciences Corporation, Zimmer Biomet Holding Inc., Berlin Heart GmbH, Jarvik Heart, Inc., and Medtronic plc.
Recent Key Strategies and Developments
In September 2021, Picard Medical, Inc (“Picard”) , a portfolio company of Hunniwell Lake Ventures, LLC, announced that it had acquired SynCardia Systems, LLC, the global leader in mechanical heart replacement technology and solution provider.
Key Sources Referred
- National Center for Biotechnology Information
- World Health Organization (WHO)
- National Library of Medicine
- The United States Food and Drug Administration
- U.S. Department of Health & Human Services
- Centers for Disease Control and Prevention
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial internal organs market analysis from 2024 to 2033 to identify the prevailing artificial internal organs market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the artificial internal organs market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global artificial internal organs market trends, key players, market segments, application areas, and market growth strategies.
Artificial Internal Organs Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 56.8 Billion |
 Growth Rate | CAGR of 7.5% |
 Forecast period | 2024 - 2033 |
 Report Pages | 280 |
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Zimmer Biomet Holding Inc., Berlin Heart GmbH, Edwards Lifesciences Corporation, Medtronic Plc., Jarvik Heart, Inc., Abbott Laboratories, SynCardia Systems LLC, Johnson & Johnson, Cochlear Limited, Boston Scientific Corporation |
Increasing demand for organ transplants, and shortage of donor organs worldwide are the upcoming trends of Artificial Internal Organs Market.
Hospitals are the leading end users of Artificial Internal Organs Market.
North America is the largest regional market for Artificial Internal Organs.
The artificial internal organs market was valued at $27.43 billion in 2023.
The major players operating in the artificial internal organs market include SynCardia Systems LLC, Abbott Laboratories, Cochlear Limited, Boston Scientific Corporation, Johnson & Johnson, Edwards Lifesciences Corporation, Zimmer Biomet Holding Inc., Berlin Heart GmbH, Jarvik Heart, Inc., and Medtronic plc.
Loading Table Of Content...
